Assad Oberai1, Bino Varghese2, Steven Cen2, Tomas Angelini3, Darryl Hwang2, Inderbir Gill4, Manju Aron5, Christopher Lau2, Vinay Duddalwar2,4. 1. Department of Aerospace and Mechanical Engineering, Univ. of Southern California, Los Angeles, CA, USA. 2. Department of Radiology, Univ. of Southern California, Los Angeles, CA, USA. 3. Department of Computer Science, Univ. of Southern California, Los Angeles, CA, USA. 4. Institute of Urology, Univ. of Southern California, Los Angeles, CA, USA. 5. Department of Pathology, Univ. of Southern California, Los Angeles, CA, USA.
Abstract
OBJECTIVE: Establish a workflow that utilizes convolutional neural nets (CNN) to classify solid, lipid-poor, contrast enhancing renal masses using multiphase contrast enhanced CT (CECT) images and to assess the performance of the resulting network. METHODS: In this institutional review board approved study of 143 patients with predominantly solid, lipid-poor, contrast enhancing renal lesions (46 benign and 97 malignant), patients with a pre-operative multiphase CECT of the abdomen and pelvis obtained between June 2009 and June 2015 were retrospectively queried. Benign renal masses included oncocytoma and lipid-poor angiomyolipoma and the malignant group included clear cell, papillary, and chromophobe carcinomas.Region of interests of whole tumor volumes were manually segmented, and CT phase images with the largest cross-section of the segmented tumor in the axial plane were used for assessment. Post-surgical pathological evaluation was used to establish diagnosis.The segmented images of renal masses were used as input to a CNN. The data were augmented and split into training (83.9%) and validation sets (16.1%) to determine the hyperparameters of the CNN. Thereafter. the performance of the resulting CNN was quantified using eightfold cross-validation. RESULTS: The CNN-based classifier demonstrated an overall accuracy of 78% (95% confidence interval: 76-80%), sensitivity of 70% (95% confidence interval: 66-74%), specificity of 81% (79-83%) and an area under the curve of 0.82. CONCLUSION: A CNN-based classifier to diagnose solid enhancing malignant renal masses based on multiphase CECT images was developed. ADVANCES IN KNOWLEDGE: It was established that a CNN-based classifier could be trained to accurately distinguish malignant renal lesions.
OBJECTIVE: Establish a workflow that utilizes convolutional neural nets (CNN) to classify solid, lipid-poor, contrast enhancing renal masses using multiphase contrast enhanced CT (CECT) images and to assess the performance of the resulting network. METHODS: In this institutional review board approved study of 143 patients with predominantly solid, lipid-poor, contrast enhancing renal lesions (46 benign and 97 malignant), patients with a pre-operative multiphase CECT of the abdomen and pelvis obtained between June 2009 and June 2015 were retrospectively queried. Benign renal masses included oncocytoma and lipid-poor angiomyolipoma and the malignant group included clear cell, papillary, and chromophobe carcinomas.Region of interests of whole tumor volumes were manually segmented, and CT phase images with the largest cross-section of the segmented tumor in the axial plane were used for assessment. Post-surgical pathological evaluation was used to establish diagnosis.The segmented images of renal masses were used as input to a CNN. The data were augmented and split into training (83.9%) and validation sets (16.1%) to determine the hyperparameters of the CNN. Thereafter. the performance of the resulting CNN was quantified using eightfold cross-validation. RESULTS: The CNN-based classifier demonstrated an overall accuracy of 78% (95% confidence interval: 76-80%), sensitivity of 70% (95% confidence interval: 66-74%), specificity of 81% (79-83%) and an area under the curve of 0.82. CONCLUSION: A CNN-based classifier to diagnose solid enhancing malignant renal masses based on multiphase CECT images was developed. ADVANCES IN KNOWLEDGE: It was established that a CNN-based classifier could be trained to accurately distinguish malignant renal lesions.
Authors: Heidi Coy; Kevin Hsieh; Willie Wu; Mahesh B Nagarajan; Jonathan R Young; Michael L Douek; Matthew S Brown; Fabien Scalzo; Steven S Raman Journal: Abdom Radiol (NY) Date: 2019-06
Authors: Michael A Gorin; Steven P Rowe; Alexander S Baras; Lilja B Solnes; Mark W Ball; Phillip M Pierorazio; Christian P Pavlovich; Jonathan I Epstein; Mehrbod S Javadi; Mohamad E Allaf Journal: Eur Urol Date: 2015-09-18 Impact factor: 20.096
Authors: R Houston Thompson; Jordan M Kurta; Matthew Kaag; Satish K Tickoo; Shilajit Kundu; Darren Katz; Lucas Nogueira; Victor E Reuter; Paul Russo Journal: J Urol Date: 2009-03-14 Impact factor: 7.450
Authors: Toshitaka Shin; Vinay A Duddalwar; Osamu Ukimura; Toru Matsugasumi; Frank Chen; Nariman Ahmadi; Andre Luis de Castro Abreu; Hiromitsu Mimata; Inderbir S Gill Journal: Urol Int Date: 2017-03-08 Impact factor: 2.089
Authors: Bino A Varghese; Frank Chen; Darryl H Hwang; Steven Y Cen; Bhushan Desai; Inderbir S Gill; Vinay A Duddalwar Journal: AJR Am J Roentgenol Date: 2018-09-21 Impact factor: 6.582
Authors: Mohamed Shehata; Ahmed Alksas; Rasha T Abouelkheir; Ahmed Elmahdy; Ahmed Shaffie; Ahmed Soliman; Mohammed Ghazal; Hadil Abu Khalifeh; Reem Salim; Ahmed Abdel Khalek Abdel Razek; Norah Saleh Alghamdi; Ayman El-Baz Journal: Sensors (Basel) Date: 2021-07-20 Impact factor: 3.576